Key result
Continuous risk stratification using history, ECG, and biomarkers identifies high-risk ACS patients for optimal management.
Why the study?
Continuous risk stratification is essential in managing patients with unstable angina and NSTEMI to identify high-risk patients and guide optimal treatment strategies.
Population
Patients with unstable angina and NSTEMI
Comparison
Early invasive strategy vs early conservative strategy; use of low molecular weight heparin and GP-IIb/IIIa receptor blockers in high-risk patients
Design
Review of ACC/AHA guideline update and related studies
Authors
Loading...
Mandates continuous multimodal risk stratification in ACS pathways; reinforces Level 1 consensus and directs research on dynamic tools.
Continuous risk stratification is essential in acute coronary syndrome to identify high-risk patients who will benefit most from aggressive therapies like early invasive strategies and targeted pharmacotherapy.
Seong‐Hoon Park (2002) conducted a review in Acute Coronary Syndrome. Risk stratification was evaluated. Continuous risk stratification using clinical history, ECG, and cardiac biomarkers is essential for identifying high-risk patients with acute coronary syndrome to guide optimal management.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: